Skip to main navigation Skip to search Skip to main content

Deoxysphingolipids activate cGAS-STING and enhance antitumor immunity

  • Stony Brook University

Research output: Contribution to journal › Article › peer-review

Abstract

Deoxysphingolipids (deoxySLs) are a class of non-canonical sphingolipids that can adversely impact mitochondrial function. Mitochondrial DNA release resulting from mitochondrial disruption can activate the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway, and in turn, promote antitumor immunity. Here, we investigated whether inducing deoxySL accumulation in colon cancer cells drives immune-specific, antitumor effects. We show that depleting serine increased deoxySLs and enhanced immune cell infiltration in colon tumors, in parallel with suppressing tumor growth. Elevating tumor deoxySL levels in mice through mutation of serine palmitoyltransferase and feeding a high alanine diet exerted similar effects, including immune-mediated tumor growth suppression. Work conducted in multiple in vitro systems identified deoxySLs as key triggers of cGAS-STING activation, an effect mediated by the release of mitochondrial DNA under mitochondrial stress. Collectively, these findings demonstrate that deoxySLs drive antitumor immunity and identify a previously unrecognized metabolic strategy for cancer therapy.

Original languageEnglish
Article number118089
JournalCell Reports
Volume45
Issue number10
DOIs
StatePublished - Oct 27 2026

Keywords

  • amino acids
  • chemokines
  • colorectal cancer
  • mitochondria

Fingerprint

Dive into the research topics of 'Deoxysphingolipids activate cGAS-STING and enhance antitumor immunity'. Together they form a unique fingerprint.

Cite this